What makes CriPec® really unique is its versatility. This allows for the creation of tailored pharmaceutical products to target unmet medical needs. CriPec®-based products display the following key features:
- Versatile as a crystal
- Our technologies are highly flexible and usable for a variety of indications.
- The nanoparticles are developed for intravenous bolus injection, infusion products as well as for local administrations (e.g. subcutaneous injection).
- A broad diversity of drugs can be transformed into controllable delivery systems, including hydrophilic and lipophilic low molecular weight compounds and peptides.
- Release time frames from days to at least several weeks are possible.
- Controlled/sustained release
- There is no burst release.
- A sustained exposure is achieved, thus decreasing the frequency of administrations.
- The therapeutic window of a drug is improved.
- Target cells are exposed to sustained drug levels, thus increasing its efficacy.
- The delivery mechanism masks the drug, thus protecting the body against (irreversible) toxicities, while simultaneously protecting the drug itself against external influences.
- Patient compliance will increase with an improved therapeutic index.
- Safe
- The polymeric delivery system itself is demonstrated to be biocompatible and non-immunogenic.